Numinus to Host Extension of MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials Pharmaceutical Investing
Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards Pharmaceutical Investing
Gilead to Present Data From Liver Disease Development Programs at The Liver Meeting® Pharmaceutical Investing
Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology Pharmaceutical Investing
AbbVie Presents New Efficacy Data on Upadacitinib in People with Active Psoriatic Arthritis and Axial Involvement at ACR Convergence 2021 Pharmaceutical Investing
AbbVie to Present New Long-term Analysis Evaluating the Sustainability of Response to RINVOQ® Among Patients with Rheumatoid Arthritis Pharmaceutical Investing
Biohaven and Pfizer Enter Strategic Collaboration for the Commercialization of Rimegepant Outside the United States Pharmaceutical Investing
Merck and Ridgeback Announce U.S. Government to Purchase 1.4 Million Additional Courses of Molnupiravir, an Investigational Oral Antiviral Medicine, for the Treatment of Mild-to-Moderate COVID-19 in At Risk Adults Pharmaceutical Investing
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BMY, EAR, HMLP, SAM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Merck Announces Receipt of Antitrust Clearance in Germany and Austria Relating to Tender Offer to Acquire Acceleron Pharma Inc. Life Science Investing
Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the AAO 2021 Annual Meeting Pharmaceutical Investing
Seegnal Inc. Establishes Strategic Commercialization Team and Appoints Arx as Investor Relations Advisor
